(종설)노인환자에 대한 약사의 복약지도

참고문헌 (42)

1. Landrum MB, "Care following Acute Myocardial Infarction in the Veterans Administration Medical Centers:A Comparison with Medicare", 39, pp.1773~1792 (2004), Health Serv Res
2. Bosanquet N, "The economics of cancer care in the UK", 5(9), pp.568~574 (2004)
3. Maziarz DM, "Cost considerations in selecting coronary artery revascularization therapy in the elderly", 4(4), pp.219~225 (2004)
4. "2002 건강보험 통계연보 제 24호", pp.801~802 (2004), 국민건강보험공단 발행
5. "2002 건강보험 통계연보 제 24호", pp.154~ (2004), 국민건강보험공단 발행
6. Levit, "National health expenditures in 1997: more slow growth", 17, pp.99~110 (1998)
7. Hughes CM, "Medication non-adherence in the elderly : how big is the problem?", 21(12), pp.793~811 (2004)
8. Cote I, "Is adherence to drug treatment correlated with health-related quality of life?", 12(6), pp.621~633 (2003)
9. Raehl CL, "Individualized drug use assessment in the elderly", 22(10), pp.1239~1248 (2002)
10. Matthews D, "Risks of progression of retinopathy and vision loss related to tight blood pressure control in type 2 diabetes mellitus:UKPDS 69", 122(11), pp.1631~1640 (2004)
11. Ciulla T, "Diabetic retinopathy and diabetic macular edema: pathophysiology,screening, and novel therapies", 26(9), pp.2653~2664 (2003)
12. Ivers RQ, "Visual impairment and falls in older adults. The Blue Mountains Eye Study.", 46, pp.58~64 (1998)
13. Nevitt M, "Risk factors for recurrent non-syncopal falls", 261, pp.2663~8 (1989)
14. Lord SR, "Physiological factors associated with falls in older community-dwelling women", 42, pp.1110~7 (1994)
15. Lord SR, "Visual risk factors for falls in older people", 49, pp.508~515 (2001)
16. Lord SR, "Multifocal glasses impair edge-contrast sensitivity and depth perception and increase the risk of falls in older people", 50, pp.1760~1766 (2002)
17. Mann RD, "Sedation with ＂non-sedating＂ antihistamines: four prescription-event monitoring studies in general practice.", 320(7243), pp.1184~1186 (2000)
18. Perucca E, "Inhibition of diazepam metabolism by fluvoxamine:a pharmacokinetic study in normal volunteers", 56(5), pp.471~6 (1994)
19. Friedman H, "Comparative pharmacokinetics of alprazolam and lorazepam in humans and in African Green Monkeys", pp.103~5 (1991)
20. Kirkwood CK, "Management of insomnia", 39, pp.688~696 (1999)
21. Stenklev NC, "The aging ear:an otomicroscopic and tympanometric study", 24(1), pp.69~76 (2004)
22. Matz GJ, "Aminoglycoside cochlear ototoxicity", 26(5), pp.705~12 (1993)
23. Jarboe JK, "The effect of quinine on outer hair cell shapecompliance and force.", 132, pp.43~50 (1999)
24. Claessen FA, "Quinine pharmacokinetics:ototoxic and cardiotoxic effects in healthy Caucasian subjects and in patients with falciparum malaria", 3(6), pp.482~489 (1998)
25. Jung TT, "Effect of round window membrane application of salicylate and indomethacin on hearing and levels of arachidonic acid metabolites in perilymph", 493, pp.81~7 (1992)
26. Lue AJ, "Chlorpromazine alters outer hair cell electromotility", 125(1), pp.71~76 (2001)
27. Schiffman SS, "Effect of psychotropic drugs on taste responses in young and elderly persons", 855, pp.732~737 (1998)
28. Ackerman BH, "Disturbances of taste and smell induced by drugs", 7(3), pp.82~96 (1997)
29. Deguchi K, "Case of ageusia from a variety of causes", 110(6), pp.598~601 (1996)
30. Neil-Dwyer G, "ACEinhibitors in hypertension:assessment of taste and smell function in clinical trials", 3, pp.169~76 (1989)
31. "http:", pdf, pp.biapi.PDF[DOI]
32. Singh G, "Toxicity profiles of disease modifying antirheumatic drugs in rheumatoid arthritis", 18(2), pp.188~94 (1991)
33. Moore AR, "Drug-induced cognitive impairment in the elderly", 15, pp.15~28 (1999)
34. Lahiri DK, "Rationale for the development of cholinesterase inhibitors as anti-Alzheimer agents", 10(25), pp.3111~3119 (2004)
35. Lemstra AW, "The cholinergic deficiency syndrome and its therapeutic implications", 49(1), pp.55~60 (2003)
36. Pappas BA, "Choline acetyltransferase activity and cognitive domain scores of Alzheimer's patients", 21(1), pp.11~17 (2000)
37. Jibson MD, "New atypical antipsychotic medications", 32, pp.215~228 (1998)
38. Yu BG, "Efficacy and safety of ziprasidone", 11(2), pp.89~96 (2001)
39. Wagstaff LR, "Statin-associated memory loss:analysis of 60 case reports and review of the literature", 23, pp.871~880 (2003)
40. Muldoon MF, "Randomized trial of the effects of simvastin on cognitive functioning in hypercholesterolemic adults", 117(11), pp.823~829 (2004)
41. Doraiswamy PM, "Statin use and hippocampal volumes in elderly subhects at risk for Alzheimer's disease:a pilot observational study", 19(5), pp.275~278 (2004)
42. Doraiswamy PM, "Statin use and hippocampal volumes in elderly subhects at risk for Alzheimer's disease:a pilot observational study", 19(5), pp.275~278 (2004)

관련 논문AI추천